The effect of subdiaphragmatic vagotomy on heart rate variability and lung inflammation in rats with severe hemorrhagic shock.
HRV
Shock
TNF-α
Vagus nerve
iNOS
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
19 04 2022
19 04 2022
Historique:
received:
14
12
2021
accepted:
28
03
2022
entrez:
20
4
2022
pubmed:
21
4
2022
medline:
22
4
2022
Statut:
epublish
Résumé
The influence of cutting the sub-diaphragmatic branch of the vagus nerve on heart rate variability (HRV) and inflammatory reaction to severe hemorrhagic shock has not been determined prior to this study. Male Sprague-Dawley rats were divided into four groups of Sham, sub-diaphragmatic vagotomized (Vag), subacute (135 ± 2 min) hemorrhagic shock (SHS), and sub-diaphragmatic vagotomized with SHS (Vag + SHS). Hemodynamic parameters were recorded and HRV calculated during multiple phases in a conscious model of hemorrhagic shock. The expressions of TNF-α and iNOS were measured in the spleen and lung tissues at the conclusion of the protocol. Decreases in blood pressure during blood withdrawal were identical in the SHS and Vag + SHS groups. However, heart rate only decreased in the Nadir-1 phase of the SHS group. HRV indicated increased power in the very-low, low, and high (VLF, LF, and HF) frequency bands during the Nadir-1 phase of the SHS and Vag + SHS groups, albeit the values were higher in the SHS group. In the recovery phase, the HF bands were only lower in the SHS group. After hemorrhagic shock followed by resuscitation, the expression of TNF-α and iNOS increased in the spleen and lung of the SHS group, and the expression of these genes was significantly lower in the Vag + SHS group than in the SHS group. Parasympathetic activity increases during the hypotensive phase of hemorrhagic shock, whereas the cardiac vagal tone decreases in the recovery phase. Sub-diapragmatic vagotomy blunts the cardiac vagal tone during hemorrhagic shock, but its effect is reversed in the recovery phase. The vagus nerve plays a role in proinflammatory responses in the lungs and spleen in subacute hemorrhagic shock followed by resuscitation.
Sections du résumé
BACKGROUND
The influence of cutting the sub-diaphragmatic branch of the vagus nerve on heart rate variability (HRV) and inflammatory reaction to severe hemorrhagic shock has not been determined prior to this study.
METHODS
Male Sprague-Dawley rats were divided into four groups of Sham, sub-diaphragmatic vagotomized (Vag), subacute (135 ± 2 min) hemorrhagic shock (SHS), and sub-diaphragmatic vagotomized with SHS (Vag + SHS). Hemodynamic parameters were recorded and HRV calculated during multiple phases in a conscious model of hemorrhagic shock. The expressions of TNF-α and iNOS were measured in the spleen and lung tissues at the conclusion of the protocol.
RESULTS
Decreases in blood pressure during blood withdrawal were identical in the SHS and Vag + SHS groups. However, heart rate only decreased in the Nadir-1 phase of the SHS group. HRV indicated increased power in the very-low, low, and high (VLF, LF, and HF) frequency bands during the Nadir-1 phase of the SHS and Vag + SHS groups, albeit the values were higher in the SHS group. In the recovery phase, the HF bands were only lower in the SHS group. After hemorrhagic shock followed by resuscitation, the expression of TNF-α and iNOS increased in the spleen and lung of the SHS group, and the expression of these genes was significantly lower in the Vag + SHS group than in the SHS group.
CONCLUSION
Parasympathetic activity increases during the hypotensive phase of hemorrhagic shock, whereas the cardiac vagal tone decreases in the recovery phase. Sub-diapragmatic vagotomy blunts the cardiac vagal tone during hemorrhagic shock, but its effect is reversed in the recovery phase. The vagus nerve plays a role in proinflammatory responses in the lungs and spleen in subacute hemorrhagic shock followed by resuscitation.
Identifiants
pubmed: 35439928
doi: 10.1186/s12872-022-02594-w
pii: 10.1186/s12872-022-02594-w
pmc: PMC9020113
doi:
Substances chimiques
Tumor Necrosis Factor-alpha
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
181Informations de copyright
© 2022. The Author(s).
Références
Front Psychol. 2017 Feb 20;8:213
pubmed: 28265249
BMC Cardiovasc Disord. 2020 Jul 11;20(1):331
pubmed: 32652932
Circulation. 2003 Mar 4;107(8):1189-94
pubmed: 12615800
FASEB J. 2011 Dec;25(12):4476-85
pubmed: 21840939
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2007 May;19(5):266-9
pubmed: 17490562
J Auton Nerv Syst. 1993 Feb;42(2):153-69
pubmed: 8450174
Circulation. 1996 Mar 1;93(5):1043-65
pubmed: 8598068
Pediatr Clin North Am. 2018 Dec;65(6):1107-1118
pubmed: 30446051
Surgery. 2005 Oct;138(4):766-71
pubmed: 16269307
Inflammation. 2017 Apr;40(2):555-565
pubmed: 28028757
Clin Exp Pharmacol Physiol. 2001 May-Jun;28(5-6):479-87
pubmed: 11428384
J Nutr Metab. 2011;2011:715361
pubmed: 21773025
Can J Physiol Pharmacol. 2021 Jul;99(7):720-728
pubmed: 33211546
Auton Neurosci. 2009 Oct 5;150(1-2):53-61
pubmed: 19482559
Biomed Pharmacother. 2019 Feb;110:930-942
pubmed: 30572197
Braz J Med Biol Res. 2017 Jan 09;50(1):e5511
pubmed: 28076450
Surgery. 2020 Mar;167(3):638-645
pubmed: 31759624
Ann Surg. 2008 Jun;247(6):929-37
pubmed: 18520219
Shock. 1998 Nov;10(5):343-6
pubmed: 9840649
Surgery. 2005 Oct;138(4):749-57; discussion 757-8
pubmed: 16269305
Front Neurosci. 2019 May 08;13:418
pubmed: 31133776
J Emerg Trauma Shock. 2012 Oct;5(4):285-95
pubmed: 23248495
Am J Physiol. 1994 May;266(5 Pt 2):H1993-2000
pubmed: 8203598
Cytokine. 2013 Feb;61(2):585-90
pubmed: 23178149
Respir Physiol Neurobiol. 2013 Jun 1;187(1):78-81
pubmed: 23410913
Brain Stimul. 2017 Sep - Oct;10(5):875-881
pubmed: 28566194
Am J Physiol. 1991 Oct;261(4 Pt 2):H1292-9
pubmed: 1833987
Shock. 2014 Apr;41(4):282-91
pubmed: 24365884
J Clin Invest. 2007 Feb;117(2):289-96
pubmed: 17273548
Surg Clin North Am. 2001 Dec;81(6):1217-62, xi-xii
pubmed: 11766174
BMC Bioinformatics. 2012 Jun 18;13:134
pubmed: 22708584
Am J Physiol. 1985 Nov;249(5 Pt 2):R638-41
pubmed: 4061684
Endocrinol Exp. 1990 Mar;24(1-2):105-16
pubmed: 2163302
J Nucl Med. 1985 Jan;26(1):72-6
pubmed: 3965655
Brain Behav Immun. 2015 Oct;49:94-100
pubmed: 25541185
J Trauma. 2007 Jan;62(1):112-9
pubmed: 17215741
Open Access Emerg Med. 2019 Aug 14;11:179-199
pubmed: 31616192
Am J Physiol. 1990 Mar;258(3 Pt 2):H713-21
pubmed: 2316686
Physiol Meas. 2011 Jun;32(6):717-29
pubmed: 21606562
Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H668-78
pubmed: 18024546
Am J Respir Cell Mol Biol. 1994 Mar;10(3):290-7
pubmed: 8117448
Am J Physiol. 1991 Feb;260(2 Pt 2):H305-18
pubmed: 1671735
Glob Adv Health Med. 2015 Jan;4(1):46-61
pubmed: 25694852
Auton Neurosci. 2003 Oct 31;108(1-2):1-11
pubmed: 14614958
Auton Neurosci. 2015 Jul;190:20-5
pubmed: 25940783